Epigral Ltd share price logo

Epigral Share Price

NSE: EPIGRAL

BSE: 543332

Small Cap

Chemical Sector

₹891.80

-34.50

(-3.72%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Epigral Stock Performance

as on February 27, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹885.00
    ₹935.00
    downward going graph

    0.76%

    Downside

    4.84%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹885.00
    ₹2,114.00
    downward going graph

    0.76%

    Downside

    137.05%

    Upside

    downward going graph

Epigral share price movements today

Previous Close
₹926.30
Open
₹935.00
Volume
3.88L
Upper Circuit
₹1,111.50
Lower Circuit
₹741.10
Day's Low - High
₹885.00 - ₹935.00
52 Week Low - High
₹885.00 - ₹2,114.00

Epigral Historical Returns

1 Month Return
-14.74 %
3 Month Return
-41.01 %
1 Year Return
-44.72 %
3 Year Return
-12.84 %
5 Year Return
+ 119.41 %

Epigral Fundamentals

as on February 27, 2026 at 4:01 pm IST

Market Cap

₹3,847.34 Cr

Return on Equity (ROE)

22.59

PE Ratio (TTM)

11.39

Return on capital employed (ROCE)

25.1

Industry PE ratio

47

Beta (LTM)

1.46

P/B Ratio

4.3

Dividend Yield

0.32

PEG Ratio

-2.39

Quarterly Earnings Growth YOY

-62.26

EPS (TTM)

82.91

Sector

Chemicals

Book Value

441.48

Technical Analysis

Bearish

View Technical Analysis

Epigral Stock Valuation

as on February 27, 2026 at 4:01 pm IST

Epigral in the last 5 years

  • Overview

  • Trends

Lowest (9.04x)

March 28, 2023

Today (11.39x)

February 27, 2026

Industry (47.00x)

February 27, 2026

Highest (38.05x)

September 24, 2024

LowHigh

Today’s Price to Earnings Ratio: 11.39x

Epigral Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Epigral with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Epigral Ltd image
Epigral Ltd
BUY3,847.3423.88%0.623572,550
C J Gelatine Products Ltd image
C J Gelatine Products Ltd
NA8.294.49%0.00-241
Link Pharma Chem Ltd image
Link Pharma Chem Ltd
NA12.12NA0.00-225
Privi Speciality Chemicals Ltd image
Privi Speciality Chemicals Ltd
BUY11,873.5072.48%0.761842,101
Tulasee Bio-Ethanol Ltd image
Tulasee Bio-Ethanol Ltd
NA16.5816.53%0.00-1NA
See all

Market expectation of Epigral Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Epigral Stock’s Investor Sentiment and Interest

Search interest for Epigral Ltd Stock has increased by 9% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:9% versus previous 30 day period

Epigral Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
562.18
454.89
478.15
471.52
524.63
651.2
626.06
645.24
627.63
606.54
587.36
597.12
Other Income
4.54
1.52
1
2.46
2.13
2.4
6.32
3.95
3.67
8.53
1.74
5.56
Total Income
566.72
456.41
479.15
473.98
526.76
653.6
632.38
649.19
631.3
615.07
589.1
602.68
Expenses
407.53
359.87
370.43
348.98
369.24
474.94
447.63
462.73
454.25
443.15
455.3
494.42
Operating Profit
154.65
95.02
107.72
122.54
155.39
176.26
178.43
182.51
173.38
163.39
132.06
102.7
Operating Profit Margin %
27.51%
20.89%
22.53%
25.99%
29.62%
27.07%
28.5%
28.29%
27.62%
26.94%
22.48%
17.2%
Profit Before Interest, Tax and Depreciation
159.18
96.54
108.72
125
157.52
178.66
184.75
186.46
177.05
171.92
133.8
108.26
Interest
18.99
18.33
21.27
20.19
13.69
14.25
27.32
-0.07
11.77
23.37
21.84
10.95
Depreciation
30.13
30.8
31.51
30.88
30.38
33.45
32.25
32.91
33.95
41.54
42.31
42.75
Profit Before Tax
110.06
47.41
55.94
73.93
113.45
130.96
125.18
153.62
131.33
107.01
69.65
54.56
Tax Paid
33.33
15.9
17.95
24.85
36.18
45.09
43.88
49.99
44.44
-53.68
18.43
15.45
Profit After Tax
76.73
31.51
37.99
49.08
77.27
85.87
81.3
103.63
86.89
160.69
51.22
39.11
Total Net profit including share of profit / Loss from associate company
76.73
31.51
37.99
49.08
77.27
85.87
81.3
103.63
86.89
160.69
51.22
39.11
EPS
18.47
7.58
9.14
11.81
18.6
20.67
19.57
24.25
20.14
37.25
11.87
9.07
Actual EPS
18.47
7.58
9.14
11.81
18.6
20.67
19.57
24.25
20.14
37.25
11.87
9.07
Adjusted EPS
18.47
7.58
9.14
11.81
18.6
20.67
19.57
24.25
20.14
37.25
11.87
9.07
Diluted EPS
18.47
7.58
9.14
11.81
18.6
20.67
19.57
24.25
20.14
37.25
11.87
9.07

Epigral Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
828.6
1,550.94
2,188.4
1,929.19
2,550.13
Other Income
2.19
4.11
7.98
6.6
16.2
Total Income
830.79
1,555.05
2,196.38
1,935.79
2,566.33
Expenses
567.27
1,041.45
1,499.47
1,447.99
1,839.41
Operating Profit
261.33
509.49
688.93
481.2
710.72
Operating Profit Margin %
31.54%
32.85%
31.48%
24.94%
27.87%
Profit Before Interest, Tax and Depreciation
263.52
513.6
696.91
487.8
726.92
Interest
29.11
44.27
65.5
73.49
53.27
Depreciation
73.54
85.91
108.95
123.56
132.56
Profit Before Tax
160.87
383.42
522.46
290.75
541.09
Tax Paid
60.02
130.63
169.17
94.88
183.4
Profit After Tax
100.84
252.79
353.29
195.87
357.69
Total Net profit including share of profit / Loss from associate company
100.84
252.79
353.29
195.87
357.69
EPS
24.27
60.84
85.03
47.13
84.68
Actual EPS
24.27
60.84
85.03
47.13
84.68
Adjusted EPS
24.27
60.84
85.03
47.13
84.68
Diluted EPS
17.26
60.84
85.03
47.13
84.68

Epigral Ltd Cash Flow

Figures in Rupees Crores

Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
229.22
283.82
626.16
397.64
440.56
Cash Flow from Investing Activities
-196.73
-454.63
-437.21
-401.1
-261.56
Cash Flow from Financing Activities
-31.89
195.21
-199.78
-7.6
-163.54
Net Cash Flow
0.58
24.41
-10.85
-11.06
15.46

Epigral Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Oct 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
71.34%
71.37%
71.38%
71.38%
71.49%
71.58%
71.58%
68.94%
68.94%
68.95%
68.83%
68.83%
68.83%
DII
0.03%
0.04%
0.04%
0.05%
0.02%
0.18%
1.17%
3.81%
4.31%
4.66%
4.79%
4.92%
5.13%
FII
0%
0%
1.15%
1.18%
1.36%
1.47%
2.09%
3.02%
3.01%
3.01%
3.05%
2.71%
2.36%
Government
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
Public
27.39%
27.4%
27.41%
27.36%
27.1%
26.74%
25.13%
24.2%
23.72%
23.35%
23.31%
23.52%
23.66%
Total Outstanding Shares
4,15,50,158
4,15,50,158
4,15,50,158
4,15,50,158
4,15,50,158
4,15,50,158
4,15,50,158
4,31,41,338
4,31,41,338
4,31,41,338
4,31,41,338
4,31,41,338
4,31,41,338
Total Shareholders
94,778
95,833
95,742
92,959
88,870
85,761
83,176
83,182
81,697
80,878
79,951
78,605
77,562

Mutual Funds that own Epigral Stock

Check out the Mutual Funds with significant holdings in Epigral.

Epigral Corporate Actions

View detailed summary of the earnings and dividend history of Epigral.

  • Epigral Ltd Earnings Results

    Epigral Ltd’s net profit fell -62.26% since last year same period to ₹39.11Cr in the Q3 2025-2026. On a quarterly growth basis, Epigral Ltd has generated -23.64% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Epigral Ltd Dividends May,2025

    In the quarter ending March 2025, Epigral Ltd has declared dividend of ₹3.50 per share on 05 May 2025 - translating a dividend yield of 0.65%.

    Read More about Dividends

Indices Featuring Epigral Stock

Check stock indices that include Epigral.

S&P BSE Commodities

₹8,265.77

-1.56 (▲130.59%)

Insights on Epigral Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 23.52% to 23.66% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 4.74% to 5.09% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 589.1 Cr → 602.68 Cr (in ₹), with an average increase of 2.3% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 68.83% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Solar Industries India Ltd has given 244.5% return, outperforming this stock by 257.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Solar Industries India Ltd has given 55.0% return, outperforming this stock by 99.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, EPIGRAL stock has moved down by -7.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 160.69 Cr → 39.11 Cr (in ₹), with an average decrease of 45.9% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 2.71% to 2.36% in Dec 2025 quarter

About Epigral Ltd

Meghmani Finechem Limited was incorporated in 2007 and is primarily engaged in the manufacturing and selling of Chlor Alkali and its Derivatives, as well as Agrochemicals and Pigments trading. Following the approval from the National Company Law Tribunal NCLT Ahmedabad Bench in May 2021, Meghmani Finechem Limited was demerged from Meghmani Organics in FY 2020-21, and is driven by the second generation of the Promoter family. The Company's Chlor Alkali business has grown from an installed capacity of 188,000 TPA in 2015 to 315,000 TPA. Investments in a Caustic Soda, Hydrogen Peroxide and a 36MW Captive Power Plant have further broadened the Company's manufacturing capacity, with the Payback from these investments being recovered in 45 years. In FY 2020-21, the Company announced the implementation of a 50,000TPA manufacturing facility for Epichlorohydrin ECH and 30,000TPA Chlorinated Polyvinyl Chloride CPVC. The facility is based on glycerin feedstock obtained from 100% renewable resources and is expected to be commissioned in the first quarter of the next financial year. The CPVC Resin project of 30,000TPA is likely to be commissioned by the second quarter of FY 2022-23.

Revenue: ₹597.12Cr as on December 2025 (Q3 FY26)
Net Profit: ₹39.11Cr as on December 2025 (Q3 FY26)
Listing date: 18 Aug, 2021
Chairperson Name: Maulik Jayantibhai Patel
OrganisationEpigral Ltd
HeadquartersAhmedabad
IndustryChemicals
CEOMaulik Jayantibhai Patel
E-voting on sharesClick here to vote

FAQs

What is Epigral share price today?

Epigral share price today stands at ₹891.8 as on at the close of the market. Epigral share today touched a day high of ₹935 and a low of ₹885.

What is the 52 week high and 52 week low range for Epigral share?

Epigral touched a 52 week high of ₹2114 and a 52 week low of ₹885. Epigral share price today i.e. is closed at ₹891.8, which is -57.81% down from its 52 week high and 0.77% up from its 52 week low.

What is Epigral's market capitalisation today?

Epigral market capitalisation is ₹3,847.34 Cr as on .

How to buy Epigral shares?

To buy Epigral shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for EPIGRAL or Epigral Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Epigral shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Epigral trading volume today?

Epigral trading volume is 3.88L as on . This means that 3.88L shares of Epigral were bought and sold on the stock market during today's trading session.